According to research report the global minimal residual disease testing market is projected to reach USD 2.3 Billion by 2027, at a CAGR of 14.0%. Increasing prevalence of cancer and...
Most biological agents enter the body directly without passing through the gastrointestinal tract, so in addition to biological activity, relevant authorities have very strict requirements on imp...
STEMart, a US-based provider of comprehensive services for all phases of medical device development, recently announced the launch of new Ethylene Oxide Sterilant Residual Testing services. The new...
